Oncology & Hematology Coding Alert

ICD-9 Coding:

Follow These Tips to Feel Certain About Coding Uncertain Neoplasms

Mastering uncertain vs. unspecified is an oncology coding essential.Unless you've got the terms "uncertain" and "unspecified" down pat, you're setting yourself up for miscoded claims. Take a look at our experts' explanations and examples to make sure you know the difference.Know How the Neoplasm Table Can HelpTo understand the uncertain/unspecified distinction, you need to comprehend the overall neoplasm diagnostic classification scheme. The ICD-9 neoplasm table distinguishes cancers as malignant, benign, uncertain, or unspecified. Starting with the malignant/benign difference will help you understand the "uncertain" classification.Malignant: A malignant neoplasm is cancerous and may be invasive or noninvasive (also called in situ), explains R.M. Stainton Jr., MD, president of Doctors' Anatomic Pathology Services in Jonesboro, Ark.For invasive cancers, you also have to choose between primary and secondary. "Primary" means that the cancer arises from surrounding cells. "Secondary" means that the cancer metastasized (spread) from a primary malignancy located elsewhere in the body.For [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All